Related Experiment Videos
Host immunologic augmentation for the control of infection
1Department of Medicine, University of Florida College of Medicine, Gainesville, USA.
Infectious Disease Clinics of North America
|June 1, 1996
Summary
Antimicrobial resistance necessitates new infection control strategies. Hematopoietic growth factors and immune therapies show promise in enhancing host immunity to combat infections and improve chemotherapy tolerance.
Area of Science:
- Immunology
- Hematology
- Infectious Diseases
Background:
- Rising antimicrobial resistance poses a significant challenge to treating infections.
- Increased chemotherapy dose-intensity requires strategies to mitigate associated risks, including infection.
- Current treatments face limitations, driving the need for novel approaches to infection control and cancer therapy.
Purpose of the Study:
- To explore alternative methods for controlling infectious diseases.
- To investigate the role of host immune enhancement in managing infections.
- To evaluate strategies for improving the efficacy and safety of high-dose chemotherapy.
Main Methods:
- Utilizing hematopoietic growth factors to stimulate immune cell production.
- Employing hematopoietic stem cell mobilization for enhanced therapeutic potential.
- Investigating the immunomodulatory effects of interferons, cytokines, immune globulins, and lymphocytes.
Main Results:
- Hematopoietic growth factors shorten neutropenia duration, reducing infection risk.
- Mobilized hematopoietic stem cells support high-dose chemotherapy administration.
- Immune-based therapies demonstrate potential in bolstering host defense.
Conclusions:
- Hematopoietic growth factors and stem cell therapies offer viable strategies for infection management and cancer treatment.
- Immunomodulatory agents like interferons and lymphocytes present promising avenues for enhancing host immunity.
- Further research into these immune-enhancing strategies is warranted to combat infectious diseases and improve patient outcomes.